chemotherapy part 1 (4) Flashcards

1
Q

sulfonamides: sulfamethoxazole
- bacteria manufacture their own _____
- sulfonamides inhibit _____ synthesis
- sulfonamides resemble _____ as structural analogues
- resistance may occur:
- -increase synthesis of _____
- -alter _____ structure
- -reduce _____ uptake

  • clinical uses:
  • -systemic: UTI
  • -topical: conjunctivitis, corneal ulcer
A
folic acid
folic acid 
PABA
PABA
enzyme 
sulfonamide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

sulfonamides: adverse effects
- blood dyscrasias
- _____
- _____ syndrome
- allergy- metabolite (PABA)
- renal damage from _____

-hallmark symptom of stevens-johnson syndrome: _____ lesion

A

photosensitivity
stevens-johnson
crystalluria
bulls eye

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

trimethoprim

  • 40,000 times greater affinity for bacterial DHFR
  • minimal effects on mammalian cells
  • _____ and _____ (1:5 ratio) act in concert with each other
  • brand names: bactrim, septra, cotrim, co-trimoxazole
  • resistance:
  • -increase synthesis of _____ (DHFR)
  • -reduce _____ to trimethoprim
A

trimethoprim
sufamethoxazole
enzyme
permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

nucleic acid synthesis inhibitors

  • fluoroquinolones
  • -ciprofloxacin
  • -levofloxacin
  • -gatifloxacin
  • -moxifloxacin
  • -ofloxacin
  • -norfloxacin
  • FDA: black box warnings on all fluoroquinolones/ increased risk of _____ damage
  • 2016: disabling and potentially permanent serious side effects can involve the tendons, muscles, joints, nerves, and central nervous system, low blood sugar and mental health problems were added in 2018
A

tendon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

fluoroquinolones

  • ciprofloxacin, norfoxacin, levofloxacin
  • -mechanism of action
  • – inhibits bacterial _____
  • —DNA gyrase converts closed circular DNA into _____ configuration
  • –prevents _____, stops _____
  • -resistance:
  • alteration of _____
  • decrease _____
A
DNA gyrase 
supercoiled 
supercoiling 
DNA replication 
DNA gyrase
permeability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

fluoroquinolones

  • ciprofloxacin
  • -_____ spectrum
  • –most _____ gram _____ and some gram _____
  • –_____
  • -adverse effects, mild (relative)
  • –GI upset: nausea vomiting diarrhea
  • -CNS: _____, _____, _____
  • -children: _____ damage
  • -not used in children under 18 year old
  • -not used in elderly patients/ _____
A
broad
aerobic 
negative
positive 
bactericidal 
dizziness 
headaches 
confusion 
cartilage 
tendonitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

metronidazole (flagyl)

  • chemically reduced to a _____ metabolite
  • -this reaction is unique to _____ bacteria
  • toxic metabolite interacts with _____
  • results in loss of _____ structure, strand breakage and resultant inhibition of nucleic acid synthesis and _____
  • _____
A
toxic 
anaerobic 
DNA
helical
cell death 
bactericidal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

metronidazole
-adverse effects:
–CNS disturbances, dizziness, lightheadedness
-GI disturbances: abdominal pain and cramps; nausea and vomiting; diarrhea
-taste: changes in _____, sharp _____ taste
-dry mouth, dark urine
seizures (high doses)
-_____ like reaction

A

sensation
metallic
disulfiram

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

metronidazole drug interactions

  • _____: disulfiram-like reaction: nausea, giddiness, flushing, abdominal cramps; accumulation of _____
  • this results due to the non conversion of _____
  • disulfiram- confusion psychotic reactions, convulsions; 2 week washout period recommended
  • _____: inhibit metabolism; increase plasma levels; monitor _____ time
  • barbiturates- decrease metronidazole effect
  • phenytoin: phenytoin toxicity
A
alcohol
acetaldehyde 
acetaldehyde
anticoagulants 
prothrombin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

vancomycin

  • mechanism of action
  • -acts by binding to _____ strand of cell wall and preventing further growth
  • effective against _____
  • pharmacokinetics
  • -not absorbed from the GI
  • -excreted unchanged via the kidneys
  • clinical uses
  • -oral, for serious GI infection
  • -slow infusion, serious systemic infection
  • -_____ injection: _____ syndrome
A

peptidoglycan
MRSA
bolus IV
red man

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

aminoglycosides

  • _____ is a prototype drug
  • gentamicin, tobramycin, amikacin
  • bind to _____ subunit and inhibit protein synthesis
  • virtually the same spectrum as _____ plus enterococci
  • used for sepsis, pneumonia
  • given only _____, at low cost ($3 a day)
  • drug monitoring required
  • hardest drug to dose
A

streptomycin
30S
flurorquinolones
IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

aminoglycosides side effects

  • _____ toxicity (irreversible) loss of _____, _____ and _____ (ototoxic)
  • _____ toxicity (reversible) monitor _____ (nephrotoxic)
  • neuromuscular blockade can occur during surgery because aminoglycosides have an additive effect with paralyzing agents
  • adding furosemide or other nephrotoxic drugs increases risk of renal damage
  • can also happen if patient is given an overdose
A
vestibular
balance
hearing
dizziness
renal
creatinine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

super bugs

  • MRSA: methicillin resistant staph aureus
  • -isolate patient and wash hands!!
  • -Rx: _____ 1g IV q12h
  • -resistant to all _____ and _____
A

vancomycin
penicillins
cephalosporins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

super bugs

  • VRE (vancomycin resistant enterococci)
  • -infects immunocompromised patients
  • -routine identification procedures in critical care areas with _____ of colonized patients
A

isolation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

future directions

  • _____: FDA 1999
  • -mix of dalfoprastin (GpA) and quinupristin (GpB)
  • -used for vancomycin resistant strep pyogenes
  • -50S binding: combination provides potency
  • -_____: FDA 2000 linezolid
  • -gram positive including MRSA/VRE
  • 50S binding along with binding to the tRNA
  • _____: FDA 2007: retapamulin
  • -topical therapy for bacterial infections
  • -bind to 50S
A

streptogramins
oxazolidinones
pleuromutilins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly